358 related articles for article (PubMed ID: 28069039)
1. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
[TBL] [Abstract][Full Text] [Related]
2. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
[TBL] [Abstract][Full Text] [Related]
3. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
4. Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.
Suemitsu R; Takeo S; Matsuzawa H; Yamaguchi M; Momosaki S; Uesugi N
J Thorac Oncol; 2010 Mar; 5(3):349-53. PubMed ID: 20009772
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
6. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
9. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
[TBL] [Abstract][Full Text] [Related]
10. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis.
He J; Li Y; An J; Hu L; Zhang J
World J Surg Oncol; 2017 Feb; 15(1):36. PubMed ID: 28148271
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.
Liptay MJ; D'amico TA; Nwogu C; Demmy TL; Wang XF; Gu L; Litle VR; Swanson SJ; Kohman LJ;
J Thorac Oncol; 2009 Feb; 4(2):198-202. PubMed ID: 19179896
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
14. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
15. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
16. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
17. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer.
Verhagen AF; Bulten J; Shirango H; Thunnissen FB; van der Drift MA; van der Bruggen W; Tjan-Heijnen VC; van Swieten HA
J Thorac Oncol; 2010 Aug; 5(8):1201-5. PubMed ID: 20588201
[TBL] [Abstract][Full Text] [Related]
19. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
[TBL] [Abstract][Full Text] [Related]
20. Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients.
Matsumura Y; Hishida T; Shimada Y; Ishii G; Aokage K; Yoshida J; Nagai K
J Thorac Oncol; 2014 Mar; 9(3):337-44. PubMed ID: 24496002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
